Exact Mass: 343.1595

Exact Mass Matches: 343.1595

Found 48 metabolites which its exact mass value is equals to given mass value 343.1595, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N1-(2,4-Dimethoxybenzyl)-n2-(2-(pyridin-2-yl) ethyl)oxalamide

N-[(2,4-dimethoxyphenyl)methyl]-N-[2-(pyridin-2-yl)ethyl]ethanediamide

C18H21N3O4 (343.1532)


N1-(2,4-Dimethoxybenzyl)-n2-(2-(pyridin-2-yl) ethyl)oxalamide is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

   

Porothramycin A

Porothramycin A

C18H21N3O4 (343.1532)


   

CHEMBL3899761

CHEMBL3899761

C23H21NO2 (343.1572)


   

JWH-073 5-hydroxyindole metabolite

JWH-073 5-hydroxyindole metabolite

C23H21NO2 (343.1572)


   

JWH 073 6-hydroxyindole metabolite

(1-butyl-6-hydroxy-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C23H21NO2 (343.1572)


   

JWH 073 7-hydroxyindole metabolite

(1-butyl-7-hydroxy-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C23H21NO2 (343.1572)


   

JWH 073 N-(4-hydroxybutyl) metabolite

(1-(4-hydroxybutyl)-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C23H21NO2 (343.1572)


   

JWH 073 N-(3-hydroxybutyl) metabolite

JWH 073 N-(3-hydroxybutyl) metabolite

C23H21NO2 (343.1572)


   

METHYL PAROXETINE

METHYL PAROXETINE

C20H22FNO3 (343.1584)


   

MMV688553

MMV688553

C18H21N3O4 (343.1532)


   

Mazethramycin B

Mazethramycin B

C18H21N3O4 (343.1532)


   

JWH 073 2-hydroxyindole metabolite

JWH 073 2-hydroxyindole metabolite

C23H21NO2 (343.1572)


   

Buflomedil HCl

Buflomedil hydrochloride

C17H26ClNO4 (343.155)


   

N-Methylparoxetine

N-Methylparoxetine

C20H22FNO3 (343.1584)


   

Porothramycin hemiaminal

Porothramycin hemiaminal

C18H21N3O4 (343.1532)


   

Met Pro Pro

Met Pro Pro

C15H25N3O4S1 (343.1566)


   

Pro Met Pro

Pro Met Pro

C15H25N3O4S1 (343.1566)


   

Pro Pro Met

Pro Pro Met

C15H25N3O4S1 (343.1566)


   

JWH 073 2-hydroxyindole

(1-butyl-2-hydroxy-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C23H21NO2 (343.1572)


   

JWH 073 4-hydroxyindole metabolite

(1-butyl-4-hydroxy-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C23H21NO2 (343.1572)


   

JWH 073 5-hydroxyindole metabolite

(1-butyl-5-hydroxy-1H-indol-3-yl)(naphthalen-1-yl)-methanone

C23H21NO2 (343.1572)


   

N1-(2,4-Dimethoxybenzyl)-N2-(2-(pyridin-2-YL)ethyl)oxalamide

N-[(2,4-dimethoxyphenyl)methyl]-N-[2-(pyridin-2-yl)ethyl]ethanediamide

C18H21N3O4 (343.1532)


   

(S)-(+)-JWH 073 N-(3-hydroxybutyl) metabolite

(S)-(+)-JWH 073 N-(3-hydroxybutyl) metabolite

C23H21NO2 (343.1572)


   

Defluoro Levofloxacin

Defluoro Levofloxacin

C18H21N3O4 (343.1532)


   

Methyl (S)-N-Tritylaziridine-2-carboxylate

Methyl (S)-N-Tritylaziridine-2-carboxylate

C23H21NO2 (343.1572)


   

ethyl 3-(benzyl(3-ethoxy-3-oxopropyl)amino)-2,2-difluoropropanoate

ethyl 3-(benzyl(3-ethoxy-3-oxopropyl)amino)-2,2-difluoropropanoate

C17H23F2NO4 (343.1595)


   

Methyl-1-tritylaziridin-2-carboxylat

Methyl-1-tritylaziridin-2-carboxylat

C23H21NO2 (343.1572)


   

Ethacridine lactate

Ethacridine lactate

C18H21N3O4 (343.1532)


B - Blood and blood forming organs > B05 - Blood substitutes and perfusion solutions > B05C - Irrigating solutions > B05CA - Antiinfectives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AA - Acridine derivatives D000890 - Anti-Infective Agents

   

2-[butyl-(8-hydroxyquinolin-2-yl)amino]quinolin-8-ol

2-[butyl-(8-hydroxyquinolin-2-yl)amino]quinolin-8-ol

C22H21N3O (343.1685)


   

(3S)-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

(3S)-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid

C18H21N3O4 (343.1532)


   

Ibopamine hydrochloride

Ibopamine hydrochloride

C17H26ClNO4 (343.155)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

N-[[1-(2-phenoxyethyl)-2-benzimidazolyl]methyl]aniline

N-[[1-(2-phenoxyethyl)-2-benzimidazolyl]methyl]aniline

C22H21N3O (343.1685)


   

4-[(2H-1,3-benzodioxol-5-yl)methyl]-N-[(furan-3-yl)methyl]piperazine-1-carboxamide

4-[(2H-1,3-benzodioxol-5-yl)methyl]-N-[(furan-3-yl)methyl]piperazine-1-carboxamide

C18H21N3O4 (343.1532)


   

(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one

(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-methyl-1,4-diazepan-2-one

C16H20F3N3O2 (343.1508)


   

1-[3-(2,4,6-Trimethoxybenzoyl)propyl]pyrrolidinium chloride

1-[3-(2,4,6-Trimethoxybenzoyl)propyl]pyrrolidinium chloride

C17H26ClNO4 (343.155)


   

2-[[[2-Methyl-1-(phenylmethyl)-5-benzimidazolyl]amino]methyl]phenol

2-[[[2-Methyl-1-(phenylmethyl)-5-benzimidazolyl]amino]methyl]phenol

C22H21N3O (343.1685)


   

Met-Pro-Pro

Met-Pro-Pro

C15H25N3O4S (343.1566)


   

2-[[Cyclohexyl(oxo)methyl]amino]acetic acid [2-(4-cyanoanilino)-2-oxoethyl] ester

2-[[Cyclohexyl(oxo)methyl]amino]acetic acid [2-(4-cyanoanilino)-2-oxoethyl] ester

C18H21N3O4 (343.1532)


   

ethyl 5-[[(E)-(3-methoxyphenyl)methylideneamino]carbamoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate

ethyl 5-[[(E)-(3-methoxyphenyl)methylideneamino]carbamoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate

C18H21N3O4 (343.1532)


   

Pro-Met-Pro

Pro-Met-Pro

C15H25N3O4S (343.1566)


   

Pro-Pro-Met

Pro-Pro-Met

C15H25N3O4S (343.1566)


   

Buflomedil hydrochloride

Buflomedil hydrochloride

C17H26ClNO4 (343.155)


D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Acrinol

Acrinol

C15H15N3O. C3H6O3 (343.1532)


   

AKT-IN-1

AKT-IN-1

C22H21N3O (343.1685)


AKT-IN-1 is an allosteric AKT inhibitor with an IC50 of 1.042 μM.

   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-2-phenylacetamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-2-phenylacetamide

C18H21N3O4 (343.1532)


   

(2e)-3-[(8r)-8-hydroxy-11-methoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl]-n,n-dimethylprop-2-enamide

(2e)-3-[(8r)-8-hydroxy-11-methoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl]-n,n-dimethylprop-2-enamide

C18H21N3O4 (343.1532)


   

3-{8-hydroxy-11-methoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl}-n,n-dimethylprop-2-enamide

3-{8-hydroxy-11-methoxy-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),4,11,13-tetraen-5-yl}-n,n-dimethylprop-2-enamide

C18H21N3O4 (343.1532)


   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-2-phenylacetamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-2-phenylacetamide

C18H21N3O4 (343.1532)